Acasti Pharma Inc.

Q2 2020 13F Holders

Symbol
ACST
CUSIP
00430K402
Type
Equity
Class
CL A NEW
Num filings
25
Total reported value, excl. options
$1.32 M
Manager Report Date Value ($000) Shares Option Type